BioBrace® Implant for Rotator Cuff Tears
(REinForce Trial)
Trial Summary
What is the purpose of this trial?
This study aims to evaluate the safety and effectiveness of arthroscopic rotator cuff repair augmented with the BioBrace® Implant vs. arthroscopic rotator cuff repair alone in subjects requiring surgical intervention for a full-thickness rotator cuff tear.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot have used oral steroids or had a steroid injection within 6 weeks before surgery. If you are on prescription narcotic pain medication, you may not be eligible to participate.
What data supports the effectiveness of the treatment Arthroscopic rotator cuff repair with BioBrace® Implant augmentation?
Research shows that using bio-composite scaffolds like BioBrace® can combine the benefits of promoting new tissue growth and providing structural strength, which may help reduce the chances of the rotator cuff tearing again after surgery. Additionally, studies on similar bioinductive collagen implants have shown improved healing rates and clinical outcomes in rotator cuff repairs.12345
Is the BioBrace® Implant generally safe for humans?
The BioBrace® Implant is designed to combine tissue growth and strength, but like other implants, it may carry risks such as tissue reaction or complications from the materials used. No specific safety issues unique to BioBrace® were highlighted, but general risks associated with similar implants include tissue reaction and complications from the materials.13467
How does the BioBrace® Implant treatment for rotator cuff tears differ from other treatments?
The BioBrace® Implant is unique because it combines the benefits of providing immediate structural strength and promoting new tissue growth, thanks to its bio-inductive scaffold made of porous collagen and bio-resorbable microfilaments. This dual function addresses the common issues of retear and insufficient tissue healing seen in traditional rotator cuff repair methods.128910
Eligibility Criteria
This trial is for men and women aged 40-70 with a full-thickness tear in their shoulder tendons, specifically the supraspinatus or infraspinatus. The tear should be between 2 to 5 cm. Participants must have had chronic shoulder pain for at least three months despite trying painkillers, anti-inflammatory drugs, steroid injections, activity changes, or physical therapy.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo arthroscopic rotator cuff repair with or without BioBrace® Implant
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Arthroscopic rotator cuff repair
- Arthroscopic rotator cuff repair with BioBrace® Implant augmentation
Find a Clinic Near You
Who Is Running the Clinical Trial?
CONMED Corporation
Lead Sponsor